| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62135-660-60 | 62135-660 | HUMAN PRESCRIPTION DRUG | Flecainide Acetate | Flecainide Acetate | TABLET | ORAL | 20230621 | N/A | ANDA | ANDA079164 | Chartwell RX, LLC | FLECAINIDE ACETATE | 50 mg/1 | 60 TABLET in 1 BOTTLE, GLASS (62135-660-60) |
| 62135-661-60 | 62135-661 | HUMAN PRESCRIPTION DRUG | Flecainide Acetate | Flecainide Acetate | TABLET | ORAL | 20230621 | N/A | ANDA | ANDA079164 | Chartwell RX, LLC | FLECAINIDE ACETATE | 100 mg/1 | 60 TABLET in 1 BOTTLE, GLASS (62135-661-60) |
| 62135-662-60 | 62135-662 | HUMAN PRESCRIPTION DRUG | Flecainide Acetate | Flecainide Acetate | TABLET | ORAL | 20230621 | N/A | ANDA | ANDA079164 | Chartwell RX, LLC | FLECAINIDE ACETATE | 150 mg/1 | 60 TABLET in 1 BOTTLE, GLASS (62135-662-60) |